Your browser doesn't support javascript.
loading
Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease.
Hubbard, Evan E; Heil, Lilian R; Merrihew, Gennifer E; Chhatwal, Jasmeer P; Farlow, Martin R; McLean, Catriona A; Ghetti, Bernardino; Newell, Kathy L; Frosch, Matthew P; Bateman, Randall J; Larson, Eric B; Keene, C Dirk; Perrin, Richard J; Montine, Thomas J; MacCoss, Michael J; Julian, Ryan R.
Afiliação
  • Hubbard EE; Department of Chemistry, University of California, Riverside, California 92521, United States.
  • Heil LR; Department of Genome Sciences, University of Washington, Seattle, Washington 98195, United States.
  • Merrihew GE; Department of Genome Sciences, University of Washington, Seattle, Washington 98195, United States.
  • Chhatwal JP; Massachusetts General Hospital, Department of Neurology, Harvard Medical School, 15 Parkman St, Suite 835, Boston Massachusetts 02114, United States.
  • Farlow MR; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States.
  • McLean CA; Department of Anatomical Pathology, Alfred Health, Melbourne VIC 3004, Australia.
  • Ghetti B; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States.
  • Newell KL; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States.
  • Frosch MP; C.S. Kubik Laboratory for Neuropathology, and Massachusetts Alzheimer Disease Research Center, Massachusetts General Hospital, Boston, Massachusetts 02114, United States.
  • Bateman RJ; Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8111, St. Louis, Missouri 63110, United States.
  • Larson EB; Kaiser Permanente Washington Health Research Institute and Department of Medicine, University of Washington, Seattle, Washington 98195, United States.
  • Keene CD; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington 98195, United States.
  • Perrin RJ; Department of Pathology and Immunology, Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri 63110, United States.
  • Montine TJ; Department of Pathology, Stanford University, Stanford, California 94305, United States.
  • MacCoss MJ; Department of Genome Sciences, University of Washington, Seattle, Washington 98195, United States.
  • Julian RR; Department of Chemistry, University of California, Riverside, California 92521, United States.
J Proteome Res ; 21(1): 118-131, 2022 01 07.
Article em En | MEDLINE | ID: mdl-34818016
ABSTRACT
One of the potential benefits of using data-independent acquisition (DIA) proteomics protocols is that information not originally targeted by the study may be present and discovered by subsequent analysis. Herein, we reanalyzed DIA data originally recorded for global proteomic analysis to look for isomerized peptides, which occur as a result of spontaneous chemical modifications to long-lived proteins. Examination of a large set of human brain samples revealed a striking relationship between Alzheimer's disease (AD) status and isomerization of aspartic acid in a peptide from tau. Relative to controls, a surprising increase in isomer abundance was found in both autosomal dominant and sporadic AD samples. To explore potential mechanisms that might account for these observations, quantitative analysis of proteins related to isomerization repair and autophagy was performed. Differences consistent with reduced autophagic flux in AD-related samples relative to controls were found for numerous proteins, including most notably p62, a recognized indicator of autophagic inhibition. These results suggest, but do not conclusively demonstrate, that lower autophagic flux may be strongly associated with loss of function in AD brains. This study illustrates that DIA data may contain unforeseen results of interest and may be particularly useful for pilot studies investigating new research directions. In this case, a promising target for future investigations into the therapy and prevention of AD has been identified.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article